SEARCH

SEARCH BY CITATION

References

  • 1
    Pelletier J-P, Martel-Pelletier J, Howell DS: Etiopathogenesis of osteoarthritis. In, Arthritis and Allied Conditions: A Textbook of Rheumatology. Edited by DJMcCarty, WJKoopman. Philadelphia, Lea and Febiger, 1996
  • 2
    Pelletier J-P, DiBattista JA, Roughley P, McCollum R, Martel-Pelletier J: Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 19: 545568, 1993
  • 3
    Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H: Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis 48: 645653, 1989
  • 4
    Pelletier J-P, McCollum R, Cloutier JM, Martel-Pelletier J: Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. J Rheumatol 22 (Suppl 43): 109114, 1995
  • 5
    Sadouk M, Pelletier J-P, Tardif G, Kiansa K, Cloutier JM, Martel-Pelletier J: Human synovial fibroblasts coexpress interleukin-1 receptor type I and type II mRNA: the increased level of the interleukin-1 receptor in osteoarthritic cells is related to an increased level of the type 1 receptor. Lab Invest 73: 347355, 1995
  • 6
    Martel-Pelletier J, McCollum R, DiBattista JA, Faure M-P, Chin JA, Fournier S, Sarfati M, Pelletier J-P: The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes: identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum 35: 530540, 1992
  • 7
    Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, Yu C, Zvaifler NJ: IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 149: 10541062, 1992
  • 8
    Pelletier J-P, Mineau F, Ranger P, Tardif G, Martel-Pelletier J: The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 4: 7784, 1996
  • 9
    Arend WP, Dayer J-M: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38: 151160, 1995
  • 10
    Arner EC, Harris RR, DiMeo TM, Collins RC, Galbraith W: Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit. J Rheumatol 22: 13381346, 1995
  • 11
    Arend WP: Interleukin-1 receptor antagonist. Adv Immunol 54: 167227, 1993
  • 12
    Baragi VM, Renkiewicz RR, Jordan H, Bonadio J, Harman JW, Roessler BJ: Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. J Clin Invest 96: 24542460, 1995
  • 13
    Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, Pelletier J-P: Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression. Arthritis Rheum 39: 15351544, 1996
  • 14
    Campion GV, Lebsack ME, Lookabaugh J, Gordon G, Catalano M, and the IL-1Ra Arthritis Study Group: Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 39: 10921101, 1996
  • 15
    Evans CH, Robbins PD: Pathways to gene therapy in rheumatoid arthritis. Curr Opin Rheumatol 8: 230234, 1996
  • 16
    Evans CH, Robbins PD: Gene therapy for arthritis. In, Gene Therapeutics: Methods and Applications of Direct Gene Transfer. Edited by JAWolff. Boston, Birkhauser, 1994
  • 17
    Bandara G, Robbins PD, Georgescu HI, Mueller GM, Glorioso JC, Evans CH: Gene transfer to synoviocytes: prospects for gene treatment for arthritis. DNA Cell Biol 11: 227231, 1992
  • 18
    Pelletier J-P, Mineau F, Raynauld J-P, Woessner JF Jr, Gunja-Smith Z, Martel-Pelletier J: Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 37: 414423, 1994
  • 19
    Bandara G, Mueller GM, Galea-Lauri J, Tindal MH, Georgescu HI, Suchanek MK, Hung GL, Glorioso JC, Robbins PD, Evans CH: Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci U S A 90: 1076410768, 1993
  • 20
    Mankin HJ, Dorfman H, Lippiello L, Zarins A: Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53: 523537, 1971
  • 21
    Pelletier J-P, Martel-Pelletier J, Ghandur-Mnaymneh L, Howell DS, Woessner JF Jr: Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 28: 554561, 1985
  • 22
    Nita I, Ghivizzani SC, Galea-Lauri J, Bandara G, Georgescu HI, Robbins PD, Evans CH: Direct gene delivery to synovium: an evaluation of potential vectors in vitro and in vivo. Arthritis Rheum 39: 820828, 1996
  • 23
    Hung GL, Galea-Lauri J, Mueller GM, Georgescu HI, Larkin LA, Suchanek MK, Tindal MH, Robbins PD, Evans CH: Suppression of intraarticular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium. Gene Ther 1: 6469, 1994
  • 24
    Makarov SS, Olsen JC, Johnston WN, Schwab JH, Anderle SK, Brown RR, Haskill JS: Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats. Gene Ther 2: 424428, 1995
  • 25
    Makarov SS, Olsen CC, Johnston WN, Anderle SK, Brown RR, Baldwin AS, Haskill JS, Schwab JH: Suppression of experimental arthritis by gene transfer of interleukin-1 receptor antagonist cDNA. Proc Natl Acad Sci U S A 93: 402406, 1996
  • 26
    Otani K, Nita IM, Macaulay W, Georgescu HI, Robbins PD, Evans CH: Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol 156: 35583562, 1996
  • 27
    Evans CH, Robbins PD, Ghivizzani SC, Herndon JK, Kang R, Tommaino MM, Wasko MC, Watkins SC, Whiteside TK, Glorioso JC, Lotze MT, Wright TM: Clinical trial to assess the safety, feasibility and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 7: 12611280, 1996
  • 28
    Palmer TD, Rosman GJ, Osborne WR, Miller AD: Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci U S A 88: 13301334, 1996
  • 29
    Tripathy SK, Black HB, Goldwasser E, Leiden JM: Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2: 545550, 1996
  • 30
    Kang R, Marui T, Ghivizzani SC, Nita IM, Georgescu HI, Suh JK, Robbins PD, Evans CH: Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. Osteoarthritis Cartilage 5: 139143, 1997